These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6115571)

  • 21. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
    Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
    Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neurohumoral mechanisms in cardiocirculatory decompensation].
    Grassi G; Mancia G
    Ann Ital Med Int; 1994 Oct; 9 Suppl():61S-67S. PubMed ID: 7857760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormalities of peripheral sympathetic nervous system control in congestive heart failure.
    Cohn JN
    Circulation; 1990 Aug; 82(2 Suppl):I59-67. PubMed ID: 1973641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness.
    Manthey J; Dietz R; Opherk D; Osterziel KJ; Leinberger H; Kübler W
    Am J Cardiol; 1992 Jul; 70(2):224-8. PubMed ID: 1626511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms and implications of autonomic nervous system dysfunction in heart failure.
    Middlekauff HR
    Curr Opin Cardiol; 1997 May; 12(3):265-75. PubMed ID: 9243084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.
    Riegger GA; Liebau G; Holzschuh M; Witkowski D; Steilner H; Kochsiek K
    Am J Cardiol; 1984 Feb; 53(4):614-8. PubMed ID: 6320625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Conversion enzyme inhibitors in the treatment of chronic congestive cardiac failure. Physiopathologic bases of their use].
    Garabedian VG
    Presse Med; 1985 Dec; 14(44):2264-7. PubMed ID: 3003732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators].
    Langes K; Bleifeld W
    Herz; 1990 Jun; 15(3):164-70. PubMed ID: 2198217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of vasopressin in congestive heart failure.
    Goldsmith SR
    Cleve Clin J Med; 2006 Sep; 73 Suppl 3():S19-23. PubMed ID: 16970149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurohumoral blockade in CHF management.
    Willenbrock R; Philipp S; Mitrovic V; Dietz R
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1 Suppl 1():24-30. PubMed ID: 11967792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in neurohumoral systems during the development of congestive heart failure: impact on cardiovascular and renal function.
    Elsner D
    Eur Heart J; 1995 Dec; 16 Suppl N():52-8. PubMed ID: 8682062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis.
    Francis GS; Siegel RM; Goldsmith SR; Olivari MT; Levine TB; Cohn JN
    Ann Intern Med; 1985 Jul; 103(1):1-6. PubMed ID: 2860833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurohormonal activation in congestive heart failure and the role of vasopressin.
    Chatterjee K
    Am J Cardiol; 2005 May; 95(9A):8B-13B. PubMed ID: 15847852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neurohormonal factors in congestive heart failure].
    Hannedouche T; Fournier JF
    Ann Med Interne (Paris); 1987; 138(2):123-9. PubMed ID: 3555207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
    Pimenta J; Pereira M; Castro A; Dias P; Azevedo A; Bettencourt P; Ferreira A
    Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unloading the heart in congestive heart failure.
    Cohn JN
    Am J Med; 1984 Aug; 77(2A):67-70. PubMed ID: 6383033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of congestive heart failure: neuroendocrine approach.
    Shmuely H; Sclarovsky S; Rosenfeld JB
    Isr J Med Sci; 1993 Jan; 29(1):6-10. PubMed ID: 8454456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurohumoral and hemodynamic changes in congestive heart failure: lack of correlation and evidence of compensatory mechanisms.
    Rouleau JL; Kortas C; Bichet D; de Champlain J
    Am Heart J; 1988 Sep; 116(3):746-57. PubMed ID: 2970771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.